Trial Profile
A phase II trial of TS-1 and weelky CDDP combined with hyperthermia as therapy of advanced and relapsed gastric cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 11 Oct 2015 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 05 Dec 2009 New trial record